Breaking news: The FDA has approved Tofersen for SOD1 ALS! @US_FDA thank you for living up to your promise of regulatory flexibility for ALS. ALS community: YOU made this happen with your relentless advocacy. Remember that. Stay tuned for updates on access to this treatment!
We are hitting the road again!! Join us and if you want updates on where we are screening next, sign up for emails at https://t.co/sz846iTjlR
Looking forward to continuing to bring more people into the fight!!!
FDA uses AA for cancer
n=84
🔹3.6%→CR (n=3)
🔹35%→PR (n=29)
🔹61%→NO RESPONSE
🔹12 mo impact
@DrCaliff_FDA@FDACBER#SomeisEnough in cancer, why not #ALS!
#NurOwn n=189
🔹35% →1.25 pt/mo slowing
🔹70%+ →27+ scale changed how 'feel & function'
🔹34+ scale→HALT PROGRESSION
Day three of #Relyvrio thank you again @synapticure
Relyvrio has such a bad taste Amylyx sent Listerine strips in the welcome packet, I am like SteveO with things that taste bad, so I have never been happier to have a feeding tube!
Today is the third anniversary of me receiving the worst news of my life : "You have #ALS"; yet I choose to be grateful to still be here, grateful for your love and support, grateful for my awesome sleeping partners. 🤣✨🤍✨
#ALSWarrior#ALSAwareness#ALSCommunity#ALSsucks
We love you back, Laura! Nothing makes us happier than making life easier for our #ALS, #PLS, and #PD patients.
Quick reminder for our #ALS patients: Synapticure has a 100% success rate in Relyvrio approvals. Click here to get started today: https://t.co/6bF499y9RH
We love you back, Laura! Nothing makes us happier than making life easier for our #ALS, #PLS, and #PD patients.
Quick reminder for our #ALS patients: Synapticure has a 100% success rate in Relyvrio approvals. Click here to get started today: https://t.co/6bF499y9RH
Matt has #ALS
Wants to live long enough so kids remember him
Asking #FDA to give he & #MAYO neurologists chance to share evidence that #NurOwnWorks
⬇️Press Release
https://t.co/lz2fgrwxAx
⬇️Sign Petition
https://t.co/S2NhIvuD3L
#DisneyWorld50#MickeyMouse#NurOwn#vacation
33 yo Josh has #ALS
Rcvd #Nurown in trial & compassionate use from top #neurologist at #UMass
FDA Let him share evidence that #NurOwnWorks
See #Muscles
Still #Walking
Slowed #Paralysis
Needs More
⬇️Sign Petition
https://t.co/S2NhIvuD3L
⬇️Press Release
https://t.co/lz2fgrwxAx
Former #Argentinian Senator @estebanbullrich sends letter to @POTUS@JoeBiden, asking FDA to exercise "broadest of regulatory flexibility"when considering approval of #NurOwn for fatal #ALS
Trial met clinical & statistical significance for people w ALSFRS-R scores of 27+
@WHCOS